Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Humacyte Inc (HUMA)

Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Humacyte Inc 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 USA

www.humacyte.com Employees: 220 P: 919-313-9633

Sector:

Medical

Description:

Humacyte Inc. is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. Humacyte Inc., formerly known as Alpha Healthcare Acquisition Corp., is based in DURHAM, N.C.

Key Statistics

Overview:

Market Capitalization, $K 241,580
Enterprise Value, $K 196,640
Shares Outstanding, K 187,271
Annual Sales, $ 0 K
Annual Net Income, $ -148,700 K
Last Quarter Sales, $ 750 K
Last Quarter Net Income, $ -17,510 K
EBIT, $ -105,390 K
EBITDA, $ -98,200 K
60-Month Beta 1.90
% of Insider Shareholders 5.10%
% of Institutional Shareholders 44.71%
Float, K 177,720
% Float 94.90%
Short Volume Ratio 0.32

Growth:

1-Year Return -69.87%
3-Year Return -49.00%
5-Year Return -87.24%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 11/12/25
Next Earnings Date 03/27/26
Earnings Per Share ttm -0.64
EPS Growth vs. Prev Qtr 41.67%
EPS Growth vs. Prev Year 57.58%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

HUMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -68.85%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 115.72
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.03
Interest Coverage -15.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar